Literature DB >> 2668486

Considerations in using psychotropic medication with dual diagnosis patients in recovery.

J E Zweben1, D E Smith.   

Abstract

This article addresses some of the issues that arise when chemically dependent patients with coexisting psychiatric disorders require medication. A history of chemical dependence may alter prescribing practices, as certain medications may have a higher abuse potential or may enhance the danger of relapse to the primary drug of abuse. Recovering patients have complex attitudes and feelings toward medications that need to be explored, particularly as they affect compliance with prescribed regimens. Issues arising in the treatment of anxiety disorders, depression, and attention deficit disorders are discussed. Guidelines are provided for therapists working with prescribing physicians, and for handling problems that may arise in conjunction with 12-Step program participation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2668486     DOI: 10.1080/02791072.1989.10472162

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  4 in total

1.  Consideration of special populations in the drug treatment system of a large metropolitan area.

Authors:  M L Polinsky; Y I Hser; C E Grella
Journal:  J Behav Health Serv Res       Date:  1998-02       Impact factor: 1.505

2.  Adherence to medication regimens and participation in dual-focus self-help groups.

Authors:  Stephen Magura; Alexandre B Laudet; Daneyal Mahmood; Andrew Rosenblum; Edward Knight
Journal:  Psychiatr Serv       Date:  2002-03       Impact factor: 3.084

Review 3.  The treatment of persons with dual diagnoses in a rural community.

Authors:  R H Howland
Journal:  Psychiatr Q       Date:  1995

4.  Dual Diagnosis Motivational Interviewing: a modification of Motivational Interviewing for substance-abusing patients with psychotic disorders.

Authors:  Steve Martino; Kathleen Carroll; Demetrios Kostas; Jennifer Perkins; Bruce Rounsaville
Journal:  J Subst Abuse Treat       Date:  2002-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.